Docket Number:13A-970104
Inventor:Jaulang Hwang, Chun-Cheng Lin, Hsiao-Ling Chiang, Fan-Dan Jan, Chiao-En Chen, Chia-Tse Shu
IP Status:Issued US 8,383,767, TW I425952
Abstract:
A novel antigen carrier, which contains the combination of receptor-mediated uptake and effective antigen presentation. The carrier protein can activate T- and B-cell efficiently and increase the immunogenicity of carbohydrate antigen.
Fields of Application:
The application includes of preparation of glycotope vaccine, anti-glycotope antibody, any low immunogenicity immunogen or small molecular, for example, phosphoserine, phosphothreonine, sialic acid, or GlcNAc et al. The antigen can conjugate with this carrier protein as a potent immunogen.
Advantages when compared to the existing technologies:
- The carrier contains high conjugation efficiency and detection easily.
- The carrier can activate T cell and B cell efficiently and increase the immunogenicity of glycoptope antigen and the induced antibody would be IgG subtype.
- Induced antibody mostly recognizes glycotope antigen rather than carrier.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
